BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 12, 2012
View Archived Issues
Pilot trial evaluates rebamipide in aspirin-induced small bowel damage
Read More
Japanese study supports in vivo antitumor activity of Golgi-disrupting agent
Read More
Xenon Pharmaceuticals enters alliance for pain therapeutics
Read More
Sangamo BioSciences begins two phase II trials in HIV
Read More
JNK inhibitor prevents hearing loss due to transient cochlear ischemia in preclinical study
Read More
Researchers describe role of Th17 cells in vaccine-induced immunity
Read More
Chinese company patents new receptor tyrosine kinase inhibitors
Read More
Janssen Pharmaceutica patents novel antifungal agents
Read More
Baxter submits supplemental BLA to FDA for Gammagard Liquid
Read More
Isis Pharmaceuticals reports phase I data on ISIS-TTRRx
Read More
University of Arkansas discloses novel vaccine vectors for Campylobacter infections
Read More
Tetragenetics flu vaccine protects against H5N1 in preclinical study
Read More
HGS provides pipeline update and goals for 2012
Read More
Novel serine/threonine-protein kinase PAK inhibitors patented by Afraxis
Read More
Guilin Sanjin Pharmaceutical claims novel saponins
Read More
Celtaxsys obtains anti-inflammatory drug from Estrellita Pharmaceuticals
Read More
Akinion begins treatment in phase I/II AKN-028 study
Read More
Scientists at Gene Signal disclose new peptides for wound healing
Read More
Lexicon Pharmaceuticals reports topline data from LX-4211/sitagliptin combination trial
Read More
Forma Therapeutics enters into exclusive alliance
Read More
EC adopts opinion on pioglitazone-containing drugs
Read More
Akebia Therapeutics spin-out company created
Read More
Biocon reports phase III data on immunotherapy for chronic plaque psoriasis
Read More
Cynapsus Therapeutics reports encouraging first-in-human data on APL-130277
Read More
Kadmon acquires anticancer candidate from Concordia Pharmaceuticals
Read More